Literature DB >> 18486124

Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors.

Sabina Frascarelli1, Sandra Ghelardoni, Grazia Chiellini, Romina Vargiu, Simonetta Ronca-Testoni, Thomas S Scanlan, David K Grandy, Riccardo Zucchi.   

Abstract

Trace amine-associated receptors, a novel class of G-protein coupled receptors which respond to trace amines but not to classical biogenic amines, have been found to be expressed in heart. Therefore, we investigated the cardiac effects of the trace amines p-tyramine, beta-phenylethylamine, octopamine, and tryptamine. Isolated rat hearts were perfused in the presence of trace amines, monitoring the hemodynamic variables. In addition, radioligand binding experiments with [3H]-p-tyramine and [125I]-3-iodothyronamine were performed in rat ventricular tissue. Octopamine, beta-phenylethylamine, and tryptamine produced a dose-dependent negative inotropic effect as shown by reduced cardiac output (IC(50)=109 microM, 159 microM, and 242 microM, respectively). In the same preparation a similar effect was produced by thyronamine and 3-iodothyronamine, with IC(50)=94 microM and 27 microM, respectively. The negative inotropic effect of octopamine was confirmed in a papillary muscle preparation. All trace amines except tryptamine increased the heart rate, but this action could be attributed to their sympathomimetic properties, since it was abolished by propranolol. The negative inotropic effect of trace amines was significantly increased by the tyrosine kinase inhibitor genistein. Specific and saturable binding of [(3)H]-p-tyramine and [125I]-3-iodothyronamine was observed in ventricular tissue. While [3H]-p-tyramine was displaced by 3-iodothyronamine, [(125)I]-3-iodothyronamine was not displaced by p-tyramine. In conclusion, trace amines and thyronamines are negative inotropic agents. Their effect appears to be mediated by a subtype of trace amine-associated receptor which is characterized by the rank of potency: 3-iodothyronamine > thyronamine = octopamine = beta-phenylethylamine, while tryptamine and p-tyramine are significantly less active.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486124     DOI: 10.1016/j.ejphar.2008.03.055

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

1.  Ractopamine, a livestock feed additive, is a full agonist at trace amine-associated receptor 1.

Authors:  Xuehong Liu; David K Grandy; Aaron Janowsky
Journal:  J Pharmacol Exp Ther       Date:  2014-05-05       Impact factor: 4.030

2.  Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.

Authors:  Helen N Panas; Laurie J Lynch; Eric J Vallender; Zhihua Xie; Guo-Lin Chen; Spencer K Lynn; Thomas S Scanlan; Gregory M Miller
Journal:  J Neurosci Res       Date:  2010-07       Impact factor: 4.164

Review 3.  Trace amine-associated receptors as emerging therapeutic targets.

Authors:  Tatyana D Sotnikova; Marc G Caron; Raul R Gainetdinov
Journal:  Mol Pharmacol       Date:  2009-04-23       Impact factor: 4.436

4.  The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors.

Authors:  Vincent Van den Eynde
Journal:  J Neural Transm (Vienna)       Date:  2021-08-09       Impact factor: 3.575

Review 5.  International Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclature.

Authors:  Janet J Maguire; William A E Parker; Steven M Foord; Tom I Bonner; Richard R Neubig; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

6.  "TAARgeting Addiction"--The Alamo Bears Witness to Another Revolution: An Overview of the Plenary Symposium of the 2015 Behavior, Biology and Chemistry Conference.

Authors:  David K Grandy; Gregory M Miller; Jun-Xu Li
Journal:  Drug Alcohol Depend       Date:  2015-11-22       Impact factor: 4.492

Review 7.  Cardiac effects of thyronamines.

Authors:  Riccardo Zucchi; Sandra Ghelardoni; Grazia Chiellini
Journal:  Heart Fail Rev       Date:  2008-11-19       Impact factor: 4.214

Review 8.  A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths.

Authors:  Peter Kenneth Gillman
Journal:  J Neural Transm (Vienna)       Date:  2018-09-25       Impact factor: 3.575

Review 9.  Minireview: 3-Iodothyronamine (T1AM): a new player on the thyroid endocrine team?

Authors:  Thomas S Scanlan
Journal:  Endocrinology       Date:  2008-12-30       Impact factor: 4.736

Review 10.  Tissue thyroid hormones and thyronamines.

Authors:  Alice Accorroni; Federica Saponaro; Riccardo Zucchi
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.